Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2012
11/07/2012EP2519633A2 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/07/2012EP2519632A2 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN102770540A Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/07/2012CN102766654A Slow virus expression vector specially promoting high expression of liver cell CYP1A2 gene, and construction method and application thereof
11/07/2012CN102766630A 6-modified bicyclic nucleic acid analogs
11/07/2012CN102766605A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
11/07/2012CN102764442A Method for preparing nano particles comprising protamine and genetic material
11/07/2012CN102764441A miRNA applied method for inhibiting inflammatory response of endothelial cell
11/07/2012CN102764428A Application of V-set and transmembrane domain containing 1 (VSTM1) protein in preparation of product for inhibiting leukemia cell proliferation
11/07/2012CN102382835B siRNAs (small interfering ribonucleic acids) for suppressing expression of PAR-1 (proteinase activated receptor-1) genes and application thereof
11/07/2012CN102028954B Preparation of recombinant adenovirus
11/07/2012CN101991863B Double-target DNA vaccine and constructing method thereof
11/07/2012CN101948546B Fusion protein SAmB as well as coding gene and applications thereof
11/07/2012CN101935687B Application of IL-12p40 siRNA to promoting liver regeneration
11/07/2012CN101804207B New application of miR-223
11/07/2012CN101353664B siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof
11/07/2012CN101134110B Q type non-viral vector and pharmaceutical composition containing the same
11/06/2012US8304530 Methods and compositions for enhancing the efficacy and specificity of RNA silencing
11/06/2012US8304397 Identification of a micro-RNA that activates expression of β-myosin heavy chain
11/06/2012US8304396 Immunostimulatory nucleic acids
11/06/2012US8304234 Compositions and methods for delivery of genetic material
11/06/2012US8303946 Administering formulation capable of inhibiting at least one host cell protein needed for replication of a virus
11/06/2012US8303567 Method for delivering a macromolecular complex to muscle cells
11/06/2012CA2577423C Therapeutic uses of inhibitors of rtp801
11/06/2012CA2493083C Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
11/06/2012CA2393467C Chordin-like molecules and uses thereof
11/06/2012CA2365532C Arpe-19 as a platform cell line for encapsulated cell-based delivery
11/01/2012WO2012149566A2 Anti-hiv group i introns and a uses thereof in treating hiv infections
11/01/2012WO2012149525A2 Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
11/01/2012WO2012149472A2 Methods, compositions, and kits for treating and preventing neurological conditions
11/01/2012WO2012149465A2 Modulation of cd36 expression
11/01/2012WO2012149416A2 Human myeloid derived suppressor cell cancer markers
11/01/2012WO2012149406A2 Assessing and treating humans with long qt syndrome
11/01/2012WO2012149386A1 Modulation of cideb expression
11/01/2012WO2012149376A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012WO2012149358A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
11/01/2012WO2012149198A2 A method for manufacturing pegylated oligonucleotides
11/01/2012WO2012149024A2 Dna aptamers for promoting remyelination
11/01/2012WO2012148538A2 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
11/01/2012WO2012148373A1 Antimir-451 for the treatment of polycythemias
11/01/2012WO2012148046A1 Anticancer and cancer-sensitizing composition comprising rrp12 inhibitor
11/01/2012WO2012147805A1 Brain-targeting functional nucleic acid and use thereof
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012106404A3 Diagnosis and treatment of neurological disorders through vipr2 and vpac2r
11/01/2012WO2012094574A3 Stabilized polyribonucleotide nanoparticles
11/01/2012WO2012094193A3 Methods for enhancing the delivery of gene-transduced cells
11/01/2012WO2012088001A3 Antiviral activity of bovine type iii interferon against foot-and-mouth disease virus
11/01/2012WO2012078637A3 Composition and method for oligonucleotide delivery
11/01/2012US20120278908 Method for the diagnosis/prognosis of age-related macular degeneration
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120276142 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/01/2012US20120276129 Neisserial antigenic peptides
11/01/2012US20120276114 Ifn-gamma inhibitors in the treatment of motoneuron diseases
11/01/2012US20120276073 Treatment of nerve injuries
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120276053 Oncolytic vaccinia virus cancer therapy
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120276010 Microorganisms for therapy
11/01/2012CA2834365A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2834200A1 A method for manufacturing pegylated oligonucleotides
11/01/2012CA2827952A1 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
10/2012
10/31/2012EP2518149A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
10/31/2012EP2518144A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor
10/31/2012EP2518142A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/31/2012EP2517731A1 Method of activating a target gene in a cell
10/31/2012EP2516648A2 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
10/31/2012EP2515947A2 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
10/31/2012EP2515883A1 Abt-263 capsule
10/31/2012DE102011018586A1 New vector system, useful e.g. as a part of a viral or non-viral gene transfer vector to control targeted expression of a therapeutic DNA sequence and as a part of transfer construct or gene construct for modifying embryonic stem cells
10/31/2012CN1612750B TACI-immunoglobulin fusion proteins
10/31/2012CN1461343B 多核苷酸 Polynucleotide
10/31/2012CN102762731A Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
10/31/2012CN102762214A Modulation of epidermal growth factor receptor ligands
10/31/2012CN102757961A Method of siRNA sequence chemical modification, product thereof, and application of product thereof
10/31/2012CN102757938A Application of VSTM1 protein in preparation of product for promoting differentiation of leukemic cells
10/31/2012CN102757483A Recombinant adenovirus for expressing porcine teschovirus type 8 VP1 protein and application thereof
10/31/2012CN102755652A Bivalent DNA (Deoxyribonucleic Acid) vaccine and preparation method thereof
10/31/2012CN102755651A Anti-skin squamous cell carcinoma medicament, i.e., antagomir-365-2
10/31/2012CN102755638A Application of AGGF1 in preparing medicines for promoting angiogenesis
10/31/2012CN102220326B SiRNA of SjLGL gene of schistosoma japonica and use thereof
10/31/2012CN102091027B Method for preparing antitumor small interfering RNA carrying magnetic nano probe
10/31/2012CN101974229B Polylactic acid-polyethylene glycol/europium doped calcium phosphate nano composite material, modified substance thereof and preparation of both
10/30/2012US8299235 RNA molecules and vectors for gene silencing
10/30/2012US8299234 siRNA hat inhibits WT1 gene expression and uses thereof
10/30/2012US8299215 Methods and compositions for treating brain diseases
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299043 Treating glaucoma, cardiovascular diseases, and renal diseases
10/30/2012US8299041 Compositions and their uses directed to acetyl-CoA carboxylases
10/30/2012US8299039 Modulation of growth hormone receptor expression and insulin-like growth factor expression
10/30/2012US8299027 Method of modulating cell survival and reagents useful for same
10/30/2012US8298826 Chimaeric vector system
10/30/2012US8298817 Vector
10/30/2012US8298797 Δ-9 elongases and their use in making polyunsaturated fatty acids
10/30/2012US8298776 Antibodies to tumor associated proteins
10/30/2012US8298528 Methods for bone regeneration using endothelial progenitor cell preparations
10/30/2012US8298527 Helicobacter system and uses thereof
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 870